Pharmacy-led Interventions to Improve Medication Adherence Among Adults with Diabetes: A Systematic Review and Meta-analysis
Overview
Authors
Affiliations
Background: Control of blood glucose and a reduced risk of complications are important treatment goals in diabetes. Medication non-adherence can influence the outcome of diabetes. Involvement of a pharmacist in diabetes care might help patients to achieve better treatment outcomes. Existing literature reviews have focused on a limited number of interventions and outcome measures, and have involved different healthcare professionals. None of the previous reviews have used a standardized effect size to compare the effects of different pharmacist-led interventions and different outcome measures.
Objective: To review pharmacist-led interventions to improve medication adherence in patients with diabetes and to assess the effectiveness of these interventions on medication adherence.
Methods: Six databases were systematically searched between March and September 2017 for randomized controlled trials: PubMed, Cochrane library, EMBASE, CINAHL, JSTOR, and Web of Science. The outcome measures used were: medication adherence, HbA1c, fasting plasma glucose (FPG), post-prandial blood glucose (PPG), or random blood glucose (RBG). Cohen's d, a standardized effect size, enabled a comparison of studies with different outcome measures. The Cochrane risk of bias tool was used to assess the quality of the studies.
Results: Fifty-nine studies were included in this review. Pharmacist-led interventions enhanced outcomes in patients with diabetes (standardized mean difference (SMD) -0.68; 95% CI -0.79, -0.58; p < 0.001). Sub-group analysis by intervention strategy, the type of intervention and outcome measures produced similar results. Further analysis showed that education, printed/digital material, training/group discussion, were more effective than other interventions.
Conclusion: This finding supports the role of the pharmacist in diabetes care to enhance medication adherence.
Bandiera C, Ng R, Mistry S, Harris E, Harris M, Aslani P Int J Equity Health. 2025; 24(1):58.
PMID: 40022158 PMC: 11869407. DOI: 10.1186/s12939-025-02415-4.
Gentilini A, Kasonde L, Babar Z J Pharm Policy Pract. 2025; 18(1):2462450.
PMID: 39968320 PMC: 11834798. DOI: 10.1080/20523211.2025.2462450.
Practice Guidelines for the Value Evaluation of Clinical Pharmacy Services (version 2).
Wu L, Lv Z, Chen M, Zheng X, Li L, Du S Front Public Health. 2025; 12:1472355.
PMID: 39877920 PMC: 11772294. DOI: 10.3389/fpubh.2024.1472355.
Impact of clinical pharmacist integration on diabetes management: a prospective cohort.
Kutluay N, Bektay M, Sumbul-Sekerci B, Sekerci A, Izzettin F BMC Health Serv Res. 2025; 25(1):107.
PMID: 39833872 PMC: 11748351. DOI: 10.1186/s12913-025-12233-7.
Tantipinichwong N, Keller M Sci Rep. 2024; 14(1):31719.
PMID: 39738189 PMC: 11685990. DOI: 10.1038/s41598-024-82285-y.